KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash from Operations: 2009-2024

Historic Cash from Operations for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $1.6 billion.

  • Bausch Health Companies' Cash from Operations changed negligibly% to $405.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 8.66%. This contributed to the annual value of $1.6 billion for FY2024, which is 54.75% up from last year.
  • According to the latest figures from FY2024, Bausch Health Companies' Cash from Operations is $1.6 billion, which was up 54.75% from $1.0 billion recorded in FY2023.
  • Bausch Health Companies' Cash from Operations' 5-year high stood at $1.6 billion during FY2024, with a 5-year trough of -$728.0 million in FY2022.
  • Its 3-year average for Cash from Operations is $633.7 million, with a median of $1.0 billion in 2023.
  • As far as peak fluctuations go, Bausch Health Companies' Cash from Operations crashed by 151.05% in 2022, and later spiked by 241.76% in 2023.
  • Over the past 5 years, Bausch Health Companies' Cash from Operations (Yearly) stood at $1.1 billion in 2020, then climbed by 28.35% to $1.4 billion in 2021, then slumped by 151.05% to -$728.0 million in 2022, then skyrocketed by 241.76% to $1.0 billion in 2023, then surged by 54.75% to $1.6 billion in 2024.